Swedish Presents SummeRun & Walk for Ovarian Cancer
July 15, 2013
Although ovarian cancer comprises only 3% of all women’s cancers, it is the fifth leading cause of women’s cancer deaths. Women who are diagnosed with advanced stage ovarian cancer have a long-term survival rate of only 10%.
When detected in its earliest stages, ovarian cancer survival rates can be as high as 90%. However, early stage symptoms are usually difficult to diagnose, are often misdiagnosed, or go undetected, which leads to nearly 75% of all ovarian cancer patients being diagnosed in advanced stages.
Through innovative research and scientific community collaboration, we can work together to reduce and prevent this disease that disproportionately affects women. We are working to support ovarian cancer research in honor of our wives, mothers, sisters, daughters, and friends.
The Marsha Rivkin Center for Ovarian Cancer Research has been working to save lives and reduce suffering through the prevention of ovarian cancer, early detection, and improved treatment. Through community donations, the Marsha Rivkin Center works to advance research related to ovarian cancer nationwide, and improve outcomes for women facing ovarian cancer. The annual SummeRun, presented by Swedish, is a particularly unique community event and fundraising opportunity that supports ovarian cancer research and the Marsha Rivkin Center’s mission.
SummeRun 2013 Race Details
- Date: Sunday July 21, 2013
- Distance: 5k Run & 5k Walk
- Day of Event Timeline:
Registration begins at the corner of Marion & Minor 6:30 a.m
Aerobics warm up 7:45 a.m.
5k Run/Walk 8:15 a.m.
Surviving Ovarian Cancer Tribute/ Awards Ceremony 9:45 a.m.
- Location: All running and walking events will start and finish at the corner of Madison and Minor.
- Registration: $30 per person (through July 17), $35 per person day-of-race. Cash, check, and credit card accepted.
Register online: Whether you choose to run or walk the 5k, select the appropriate registration option on the SummeRun homepage. On-line registration available until 5pm on Wednesday July 17, 2013.
If you’re hoping to take part in the run or walk but are unable to make it on the day of the event – don’t worry, you can register to be a virtual walker and still participate! You can also make a donation to the SummeRun here; 100% of proceeds benefit the Marsha Rivkin Center for Ovarian Cancer Research.
Also, Dr. Saul Rivkin, medical oncologist at Swedish Cancer Institute and founder of the Marsha Rivkin Center for Ovarian Cancer Research, retired in July of 2013. Dr. Rivkin spent 48 years practicing medicine and joined Swedish in 1971 as one of the hospitals first medical oncologists. In recognition of Dr. Rivkin’s investments to ovarian cancer research, the Marsha Rivkin Center has announced the formation of the Saul Rivkin Innovation Fund. This new fund will help provide support to the Marsha Rivkin Center for emerging research and innovative opportunities. Learn more about Dr. Rivkin’s retirement and the new fund here.
For more information, call 206-215-6700 or visit www.summerun.org.